BofA analyst Anna Lizzul raised the firm’s price target on Clorox to $140 from $130 and keeps an Underperform rating on the shares after fiscal Q3 results came in better than expected. While positive on the Q3 margin improvement, the firm still sees reason to be cautious on the sustainability of volume and share trends in a more challenging macro environment.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CLX:
- Clorox price target raised to $162 from $148 at UBS
- Clorox price target raised to $185 from $165 at Raymond James
- Clorox price target raised to $151 from $137 at RBC Capital
- Clorox Reports Q3 Fiscal Year 2023 Results, Updates Outlook
- Clorox raises FY23 adjusted EPS view to $4.35-$4.50 from $4.05-$4.30
